Last reviewed · How we verify
NCT04342468: BPV
Blood Pressure Variability and Cardiovascular Disease Events in Patients With Hypertension
trial testing non-interventional in Blood Pressure Variability in 1,736 participants. Completed in 31 December 2019.
4 July 2019
Quick facts
| Lead sponsor | University of Malaya |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,736 |
| Start date | 14 July 2017 |
| Primary completion | 4 July 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Malaysia |
Drugs / interventions tested
- non-interventional
Conditions studied
- Blood Pressure Variability — all drugs for Blood Pressure Variability →
- Hypertension — all drugs for Hypertension →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
University of Malaya
Who can join
18 and older, any sex, with Blood Pressure Variability or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cardiovascular Disease (CV) including stroke is the leading cause of death in Malaysia Hypertension is a major contributor to this. Prevalence of hypertension in Malaysia is high (42%) in adults age 30 years or older. Besides the actual blood pressure (BP) level recently, blood pressure variability (BPV) has been recognized as an independent and strong predictor of CV events especially strokes. However, data on the BP variability and its relationship to CV events is very limited in Asia, particularly in Malaysia. Hence the investigators aim to study BPV and its relationship to CV events in treated hypertensive patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04342468
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of non-interventional
Trials testing the same drug.
- NCT07008963 — Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant · completed
- NCT07021443 — The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting · completed
- NCT05639660 — Clinical Implication of Aflibercept in PCV Treatment in China · unknown
- NCT04492384 — Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients · completed
- NCT04158505 — Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer · unknown
Other recruiting trials for Blood Pressure Variability
Currently open trials in the same condition.
- NCT05756257 — Blood Pressure Variability and Ischemic Stroke Outcome · recruiting
Other University of Malaya trials
Trials by the same sponsor.
- NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
- NCT07522463 — Enhancing Attention and Processing Speed Through Home-based Music Rehabilitation Program After Stroke in Malaysia · NA · not yet recruiting
- NCT07341802 — Pilot Feasibility Study of a Fall Prevention Exercise Programme for Community-dwelling Older Adults in Nanchang, China · NA · recruiting
- NCT07452705 — Small Study Comparing Two Pain Medicines in Teenagers for Pain Control After Scoliosis Corrective Surgery. · NA · not yet recruiting
- NCT07369596 — Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04342468 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Malaya
- Last refreshed: 16 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04342468.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing